Skip to content Skip to menu

MA welcomes the Australian Consensus Framework

Friday, 20 July 2018

Media Release

Medicines Australia is delighted to announce the signing of the Australian Consensus Framework for ethical collaboration in the healthcare sector.  Medicines Australia has been a foundation collaborator in the development of the consensus framework.

Launched today in Tokyo, at the 2018 APEC (Asia Pacific Economic Cooperation) Business Ethics for Small and Medium Enterprises Forum, the framework has been endorsed by the Federal Minister for Health the Hon. Greg Hunt MP as well as state and territory health ministers, and has been jointly signed by over 50 other peak health-related bodies in Australia.

Medicines Australia CEO Elizabeth de Somer said: “The healthcare system in Australia is a complex ecosystem, with many, many participants delivering healthcare to Australians.  The Australian Consensus Framework for Ethical Collaboration describes our shared commitment to ethical conduct amongst organisations in the health care sector.”

“By working with our stakeholders and the wider health care community, we have developed a sound framework that promotes transparency, cooperation and ethical conduct.” said Mrs de Somer.

“It’s wonderful to see so many organisations co-operate to clearly articulate how the work they do together will always put the best interests of patients first and foremost,” said Mrs de Somer.

The Consensus Framework for Ethical Collaboration in the Health Sector is available online.

Ends- More information – Natalie Wimmer – 0450 728 660


As COVID19 continues to spread, our thoughts go out to anyone who has been infected or impacted. We hope that you are taking the necessary precautions to keep safe and well, both at work and at home.

Medicines Australia continues to monitor the situation and take advice from the Department of Health and the World Health Organisation. We are focused on responding to the important short-term issues but are also ensuring we stay balanced and maintain a focus on the medium and long-term business for our industry along with the well-being of our people.

At Medicines Australia we have initiated the following to ensure we support containment measures to provide business continuity and the well-being of our staff.

  • All non-essential travel has been restricted or cancelled
  • All face-to-face meetings (with external stakeholders and members) have been changed to virtual meetings (where appropriate)
  • Staff have been provided with the latest official information on COVID-19 through a hot-link on the office intranet; this information is regularly monitored and updated
  • Flexible working arrangements are covered in our HR policy which will allow staff to work remotely, if or when required
  • Current IT infrastructure enables staff to work remotely and will be in use if any person needs to self-isolate
  • Visual reminders have been displayed around the office, providing information about best hygiene practices
  • Extra hand-sanitiser, tissues and cleaning products have been supplied to staff for their work spaces

Our latest information is located at